Clinical Trial: Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Phase II Trial of Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma

Brief Summary:

This research study is studying a combination of two drugs as a possible treatment for Leptomeningeal Metastases from Melanoma.

The names of the study interventions involved in this study are:

  • Ipilimumab
  • Nivolumab